Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05590702

French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings

Sponsor: French Innovative Leukemia Organisation

View on ClinicalTrials.gov

Summary

Chronic lymphocytic leukemia (CLL) is the most frequent form of leukemia in the Western World. The disease is characterized by the accumulation and proliferation of mature, monoclonal, CD5+ B-cells with specific immunophenotype in the peripheral blood (above 5x109/L), bone marrow and secondary lymphoid organs. Small lymphocytic leukemia (SLL) is characterized by similar tumor cells but without increased lymphocyte count. The management of these patients have considerably changed over the last decade. Indeed, beyond chemo-immunotherapy, multiple targeted therapies have been approved on the basis of phase 2 and randomized phase 3 clinical trials and have subsequently been used in daily practice. The management of patients with SLL is similar to that of those with CLL. In addition to therapeutic advances, the advent of new sequencing technologies has also identified CLL genetic features that are now being incorporated in patient routine evaluation. We here propose to set a large-scale prospective and non-interventional study including patients with symptomatic CLL/SLL with the aim to evaluate the real-world clinical management of these patients and to identify the impact of treatments and therapeutic trajectories on long-term outcome.

Official title: French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings. A FILO Study.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2022-11-11

Completion Date

2032-12-01

Last Updated

2025-12-03

Healthy Volunteers

No

Conditions

Interventions

DRUG

First line therapy

Patient with CLL or SLL requiring a therapeutic strategy according to iwCLL criteria or investigator evaluation will be identified in MCM (multidisciplinary collegial meeting). Patients will be treated and managed according to the decision of their physicians and the related MDM. No treatment plan is recommended in the setting of this non-interventional study.

Locations (57)

AMIENS - CH Amiens Picardie Site Sud

Amiens, France

Angers Chu

Angers, France

ANNECY - CH Annecy Genevois

Annecy, France

ARGENTEUIL - Centre hospitalier Victor Dupouy

Argenteuil, France

AVIGNON - Centre Hospitalier

Avignon, France

BESANCON - Hôpital Jean Minjoz

Besançon, France

BEZIERS - Centre Hospitalier - Hématologie

Béziers, France

BLOIS CH

Blois, France

APHP - Hôpital Avicenne

Bobigny, France

APHP - Hôpital Jean Verdier

Bondy, France

BOURGOUIN-JALLIEU - CH Pierre Oudot

Bourgoin, France

BREST - Hôpital Morvan - Hématologie Clinique

Brest, France

CAEN - IHBN - Hématologie Clinique

Caen, France

CERGY PONTOISE - CH René Dubos

Cergy-Pontoise, France

CHAMBERY - CH Métropole Savoie

Chambéry, France

Clermont-Ferrand - Chu Estaing

Clermont-Ferrand, France

Corbeil-Essonnes - Chsf

Corbeil-Essonnes, France

Dijon Chu

Dijon, France

GRENOBLE GHM - Institut Daniel Hollard

Grenoble, France

Grenoble - CHUGA - Hématologie Clinique

Grenoble, France

La Roche Sur Yon - Chd Vendee

La Roche-sur-Yon, France

Le Mans CH

Le Mans, France

LENS - GHT Artois

Lens, France

LIBOURNE - Hôpital Robert Boulin

Libourne, France

LILLE GHICL - Hôpital Saint Vincent de Paul

Lille, France

LILLE CHU - Hôpital Claude Huriez

Lille, France

LIMOGES - CHU Dupuytren 1

Limoges, France

LYON-Centre Léon Bérard

Lyon, France

METZ-THIONVILLE CHR- Hôpital de Mercy

Metz, France

MONTPELLIER - Hôpital Saint-Eloi - Hématologie Clinique

Montpellier, France

MORLAIX - CH des pays de Morlaix

Morlaix, France

Mulhouse - Ghrmsa

Mulhouse, France

NANTES - Hôpital Hôtel Dieu - Hématologie Clinique

Nantes, France

NIMES - CHU Caremeau

Nîmes, France

ORLEANS - CHR - Hématologie

Orléans, France

APHP - HOPITAL COCHIN - Hématologie

Paris, France

APHP - Hôpital Pitié Salpêtrière - Hématologie

Paris, France

PERPIGNAN - CH St Jean - Hématologie Clinique

Perpignan, France

Bordeaux Pessac

Pessac, France

Perigueux - Ch

Périgueux, France

LYON HCL - CH Lyon Sud

Pierre-Bénite, France

QUIMPER - CH de Cornouaille

Quimper, France

Reims Chu

Reims, France

RENNES - CHU Pontchaillou - Hématologie Clinique

Rennes, France

RENNES - Hôpital Pontchaillou - Hématologie

Rennes, France

ROUEN - Centre Henri Becquerel - Service Hématologie Clinique

Rouen, France

SAINT-BRIEUC - Hôpila Yves Le Foll

Saint-Brieuc, France

La Reunion - Gh Site Sud

Saint-Pierre, France

ST ETIENNE - CHU et Institut De Cancérologie Lucien Neuwirth

Saint-Priest-en-Jarez, France

Strasbourg - Icans

Strasbourg, France

Toulouse - IUCT Oncopole - Service d'Hématologie

Toulouse, France

TOURS - Hôpital Bretonneau

Tours, France

Troyes Ch

Troyes, France

NANCY - CHU Brabois

Vandœuvre-lès-Nancy, France

Vannes - Chba

Vannes, France

VERSAILLES - Hôpital André Mignot

Versailles, France

Villejuif Igr

Villejuif, France